682 related articles for article (PubMed ID: 18190629)
1. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
[TBL] [Abstract][Full Text] [Related]
2. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial.
Sommer F; Klotz T; Engelmann U
Asian J Androl; 2007 Jan; 9(1):134-41. PubMed ID: 17187165
[TBL] [Abstract][Full Text] [Related]
3. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
[TBL] [Abstract][Full Text] [Related]
5. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
[TBL] [Abstract][Full Text] [Related]
6. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study.
Zumbé J; Porst H; Sommer F; Grohmann W; Beneke M; Ulbrich E
Eur Urol; 2008 Jul; 54(1):204-10. PubMed ID: 18395326
[TBL] [Abstract][Full Text] [Related]
7. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury.
Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wilkins HJ; Wachs BH;
Neurology; 2006 Jan; 66(2):210-6. PubMed ID: 16434656
[TBL] [Abstract][Full Text] [Related]
9. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
Bannowsky A; Schulze H; van der Horst C; Hautmann S; Jünemann KP
BJU Int; 2008 May; 101(10):1279-83. PubMed ID: 18284406
[TBL] [Abstract][Full Text] [Related]
10. Up-titration of vardena fi l dose from 10 mg to 20 mg improved erectile function in men with spinal cord injury.
Kimoto Y; Sakamoto S; Fujikawa K; Tachibana T; Yamamoto N; Otani T
Int J Urol; 2006 Nov; 13(11):1428-33. PubMed ID: 17083398
[TBL] [Abstract][Full Text] [Related]
11. First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I.
Valiquette L; Montorsi F; Auerbach S;
Int J Clin Pract; 2006 Nov; 60(11):1378-85. PubMed ID: 17073835
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
13. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
Tan HM; Chin CM; Chua CB; Gatchalian E; Kongkanand A; Moh CL; Ng FC; Ratana-Olarn K; Serrano D; Taher A; Tambi I; Tantiwong A; Chen MW; Yip WC
Asian J Androl; 2008 May; 10(3):495-502. PubMed ID: 18385912
[TBL] [Abstract][Full Text] [Related]
15. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners.
Ralph D; Eardley I; Kell P; Dean J; Hackett G; Collins O; Edwards D
BJU Int; 2007 Jul; 100(1):130-6. PubMed ID: 17488308
[TBL] [Abstract][Full Text] [Related]
16. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
17. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
[TBL] [Abstract][Full Text] [Related]
18. Comparison of international index of erectile function with nocturnal penile tumescence and rigidity testing in evaluation of erectile dysfunction.
Tokatli Z; Akand M; Yaman O; Gulpinar O; Anafarta K
Int J Impot Res; 2006; 18(2):186-9. PubMed ID: 16151473
[TBL] [Abstract][Full Text] [Related]
19. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
Porst H; Sharlip ID; Hatzichristou D; Rubio-Aurioles E; Gittelman M; Stancil BN; Smith PM; Wilkins HJ; Pommerville P;
Eur Urol; 2006 Nov; 50(5):1086-94; discussion 1094-5. PubMed ID: 16820261
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial.
Porst H; Rosen R; Padma-Nathan H; Goldstein I; Giuliano F; Ulbrich E; Bandel T
Int J Impot Res; 2001 Aug; 13(4):192-9. PubMed ID: 11494074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
